🔎 Trials Near Me

Home › Acute Myeloid Leukemia › Missouri › Kansas City

Acute Myeloid Leukemia clinical trials in Kansas City, MO

15 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • University Health Truman Medical Center, Kansas City
  • University of Kansas Cancer Center - Briarcliff, Kansas City
  • University of Kansas Cancer Center - North, Kansas City
  • and 1 more
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Kansas City Veterans Affairs Medical Center, Kansas City
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away
Ages 18 to 59 · All sexes · Updated Sep 28, 2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away
Ages 18 to 59 · All sexes · Updated Sep 22, 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecruitingPhase 3
  • Children's Mercy Hospitals and Clinics, Kansas City
6 Months – 21 Years · All sexes · Updated Sep 17, 2026 · NCT04293562

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

RecruitingPhase 1
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT05886049

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RecruitingPhase 3
  • The Children's Mercy Hospital - Adele Hall Campus, Kansas City
29 Days – 21 Years · All sexes · Updated Aug 24, 2026 · NCT05183035

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RecruitingPhase 1
  • Children's Mercy Hospital of Kansas City, Kansas City
Ages 1 to 30 · All sexes · Updated Aug 3, 2026 · NCT06177067

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

RecruitingPhase 3
  • University of Kansas Cancer Center, Westwood · 5 mi away
Ages 18 to 75 · All sexes · Updated Jul 17, 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Children's Mercy Hospital and Clinics, Kansas City
  • University of Kansas, Westwood · 5 mi away
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

RecruitingPhase 1
  • University of Kansas Cancer Center, Westwood · 5 mi away
Ages 18 to 65 · All sexes · Updated Mar 25, 2026 · NCT03533816

About Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.

More about Acute Myeloid Leukemia on MedlinePlus

Acute Myeloid Leukemia trials in other cities

Other studies in Kansas City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.